Factory 99% Linezolid Powder CAS 165800-03-3 Chemical Intermediate Linezolid

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A743
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Linezolid
• CAS: 165800-03-3
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Linezolid
Appearance	White Powder
CAS NO.	165800-03-3
MF	C16H20FN3O4
Storage	Keep in a cool, dry, dark location

 

Linezolid, is a synthetic antibacterial agent belonging to the class of oxazolidinone antibiotics. It is characterized by its broad-spectrum activity against various Gram-positive bacteria, including those resistant to other antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA). Linezolid has a molecular formula of C16H20FN3O4 and a molecular weight of 337.35 g/mol.

 

1. Treatment of Infections: Linezolid is primarily used for the treatment of infections caused by susceptible Gram-positive bacteria, including those resistant to other commonly used antibiotics. It is particularly effective in cases where other therapies have failed or are not suitable.
2. Hospital and Community Settings: Due to its broad-spectrum activity, Linezolid is used in both hospital and community settings to treat a wide range of infections, including pneumonia, skin and soft tissue infections, and bloodstream infections.
3. Combination Therapy: In some cases, Linezolid may be used in combination with other antibiotics to enhance the effectiveness of the treatment and broaden the spectrum of activity against different bacteria.

1. Bacterial Inhibition: Linezolid functions by inhibiting the synthesis of proteins in bacteria, which is essential for their growth and survival. By blocking this process, Linezolid effectively stops the bacteria from multiplying and causing further infection.
2. Broad-Spectrum Activity: It exhibits activity against a wide range of Gram-positive bacteria, including those that are resistant to other antibiotics. This makes Linezolid a valuable option in the treatment of infections caused by multidrug-resistant bacteria.
3. Improved Patient Outcomes: By effectively inhibiting bacterial growth and reducing the duration of infections, Linezolid can improve patient outcomes, reduce the need for hospitalization, and decrease the risk of complications associated with infections.